Wenmin Fu

Dr. Wenmin Fu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Molecular Therapy-Oncolytics
Verified
Journal Article
Open access
RLRuitao Lu
Ruitao Lu
GWGuangxian Wu
Guangxian Wu
MCMeiling Chen
Meiling Chen
DJDongmei Ji
Dongmei Ji
YLYonghong Liu
Yonghong Liu
WFWenmin Fu
Wenmin Fu
In this study, we discovered that two human oral squamous carcinoma cell (OSCC) lines, SCC9 and SCC25, exhibited varied levels of permissivity to oncolytic HSV-1 T1012G replication and the differential virus yields may associate with the constitutive accumulation of two deubiquitinating enzymes USP18 and USP20 in tumor cells. USP18 and USP20 belong to the ubiquitin-specific protease family, mediating the deubiquitination of targets and promoting antiviral responses. Depletion of USP18 or USP20 in SCC9 cells increased T1012G virus yields; overexpression of USP18 or USP20 in SCC25 cells down-regulated T1012G virus replication. In addition, STING as a verified substrate of USP18 and USP20, was found to affect the virus multiplication of T1012G in SCC9 cells. STING knockdown led to an increase in T1012G virus yields in SCC9 cells. Besides, we introduced a deubiquitinating enzyme inhibitor GSK2643943A targeting USP20 and evaluated its effects on viral replication and tumor killing in vitro and in vivo. The results showed that the combination of GSK2643934A and T1012G treatment brought a profound anti-tumor efficacy in mice bearing SCC9 tumors. This report explored factors that play roles in mediating oHSV-1 replication in OSCC tumor cells, facilitating to offer potential targets to improve oHSV-1 oncolytic efficacy and develop candidates of biomarkers to predict the efficiency of oHSV-1 multiplication in tumors.

27 October 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YRYong Ren
Yong Ren
MCMeiling Chen
Meiling Chen
GWGuangxian Wu
Guangxian Wu
DJDongmei Ji
Dongmei Ji
GZGrace Guoying Zhou
Grace Guoying Zhou
WFWenmin Fu
Wenmin Fu
Increasing studies demonstrated that oncolytic activities of oHSV-1 are limited to the capacity of virus replicating in tumors. In order to potentiate the oHSV-1 oncolytic activity and expand the application of oHSV-1 treatment in multiple types of tumors, it is critical to explore the potential factors or mechanisms mediating tumor resistance to oHSV-1 infection. Here we evaluated the levels of oHSV-1 multiplication in various tumor cell lines and showed that glioblastoma cell line A172 had the lowest virus yields but intrinsically accumulated the highest levels of Mx2 protein. Subsequently we demonstrated that genetic depletion of Mx2 specifically enhanced oHSV-1 productive replication in A172 cells through promoting the nuclear translocation of uncoated viral genomic DNA and down-regulating innate antiviral response. In the further investigation, we found that Mx2 knockdown could alter the intrinsic mRNA accumulation of diverse sets innate immune genes in A172 cells, in particular DHX36 and MyD88. Mx2 depletion led to a decrease in mRNA levels of MyD88 and DHX36 in A172 cells and MyD88/DHX36 knockdown increased virus yield in A172 cells and decreased the production of IFNα, activation of IRF3 activity and NF-κB signaling in A172 cells. This shed new lights on understanding the roles of some intrinsic antiviral genes in oHSV-1 resistance, facilitating to offer potential targets to improve oHSV-1 oncolytic efficacy and develop candidates of biomarkers to predict the efficiency of oHSV-1 multiplication in tumors.

1 January 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
YLYunting Lin
Yunting Lin
RLRuitao Lu
Ruitao Lu
JHJingmei Hou
Jingmei Hou
GZGrace Zhou
Grace Zhou
WFWenmin Fu
Wenmin Fu

7 September 2020 in Virologica Sinica
Verified
Journal Article
Closed access
PDF file
HJHaifang Jiang
Haifang Jiang
JWJiaming Wu
Jiaming Wu
XLXianjie Liu
Xianjie Liu
RLRuitao Lu
Ruitao Lu
MZManling Zhou
Manling Zhou
WFWenmin Fu
Wenmin Fu